IntrinsicIntrinsic
← Scroll for more →

Financial Statements — BYOP

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q4 2024
Cash & Equivalents116.090.490.330.560.02
Total Current Assets298.169.890.330.570.04
Property, Plant & Equipment0.36--------
Goodwill31.11--------
Total Non-current Assets*35.640.010.010.000.01
Total Assets333.809.900.340.570.05
Accounts Payable218.120.030.030.020.02
Total Current Liabilities306.470.880.880.801.10
Long-term Debt0.20--------
Total Non-current Liabilities*0.610.000.000.000.00
Total Liabilities307.070.880.880.801.10
Retained Earnings(13.08)(29.35)(29.02)(27.44)(26.31)
Total Stockholder Equity*26.729.02(0.55)(0.23)(0.70)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total Revenue589.19----------
Cost of Revenue347.05----------
Gross Profit22.12----------
Research & Development0.000.000.000.000.000.00
Selling, General & Admin4.980.331.580.330.22--
Total Operating Expenses4.980.331.580.330.22--
Operating Income17.14(0.33)(1.58)(0.33)(0.22)--
Pretax Income13.77(0.34)(1.58)(0.34)(0.23)--
Tax Provision(2.50)----------
Net Income16.27(0.34)(1.58)(0.34)(0.23)(0.56)
Basic EPS0.26(0.01)(0.03)(0.01)0.00--
Diluted EPS0.26(0.01)(0.03)(0.01)0.00--
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q1 2025
Operating Cash Flow107.97(0.28)(0.33)(0.37)(0.04)
Capital Expenditures0.03--------
Free Cash Flow*107.94--------
Investing Cash Flow18.68(1.00)------
Financing Cash Flow(11.05)1.440.100.900.06
← Scroll for more columns →

* Derived from reported values